3rd Pharmaceutical Leadership Summit
Upcoming SlideShare
Loading in...5
×
 

3rd Pharmaceutical Leadership Summit

on

  • 1,975 views

 

Statistics

Views

Total Views
1,975
Views on SlideShare
1,974
Embed Views
1

Actions

Likes
1
Downloads
43
Comments
0

1 Embed 1

http://www.slideshare.net 1

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

3rd Pharmaceutical Leadership Summit 3rd Pharmaceutical Leadership Summit Document Transcript

  • & THE MAGAZINE FOR THE PHARMA LEADERS 2010 Friday, Saturday,25th & 26th June,2010, @ listen to the Policy Makers Shri Ashok Chavan Hon'ble Chief Minister Government of Maharastra Shri Srikant Jena Hon'ble Union Minister of State for Chemicals & Fertilizers, GOI “LIMITLESS LEADERSHIP” Shri Sanjay Nirupam Hon'ble Member of Parliament BRINGING TODAY, Government of India TOMORROW, Dr Surinder Singh,DCGI Ministry of Health & Family Affairs &BEYOND Government of India Commissioner, PLAN NOW TO ATTENDTHE NATION’S FDA Govt of Maharastra BIGGEST EVENT AND HEAR FROM FOREMOST Great content and speakers PHARMA LEADERS Details inside Insights from 40 of the Top 100 Companies Early Bird Register before 7th June 2010 SUMMIT PARTNERS HOSPITALITY PARTNER LEADERSHIP PARTNER KNOWLEDGE PARTNER PRINTING & PACKAGING PARTNER
  • The only Summit you need Dear 1 / The Speakers 5 VP insights in addition to a host of expert speakers including 60 of Colleague... top 100 big pharma & Biotech companies. You will proft from their vision and take away powerful new strategies and solutions to give fresh impetus to the way you tackle the challenges you face. 2 / The Networking During the 18+ hours of dedicated networking, you’ll rub shoulders New Faces for a New Pharma with the sharpest minds in marketing. No other event can provide you with 2 days of business focused networking with some of the most When talking about pharmaceutical leadership, infuential people in your field. “transformational” is the descriptor of choice. With the regulatory landscape evolving rapidly, traditional pharma cocompanies taking the plunge into biotechnology and specialty 3 / The Topics medicine, and the lifespan of products shrinking, leaders are We have thoroughly researched this area in a bid to uncover the needed who can push changes in their organizations and within hottest topics specifc to people in your position. Senior marketing and the pharmaceutical industry. To determine who are today's brand executives from all top 60 pharma Companies executives on the rise, Pharmaceutical Leadership Summit 2010 sought the agents of change within the industry, the 4 / The Case Studies executives who are helping to take their companies in new and Learn through a proven formulary of marketing examples, with different directions. take away best practice techniques. No other event can deliver such knowledgeable insights and answers to key challenges you face. Agents of change are appearing throughout organizations. Starting at the back of the value chain are the research and A glimpse of dazzling and scintillating award evening development transformers, who are taking an accelerated, disease-centric approach to R&D versus a therapeutic area approach. Further up are the commercial transformers, changing their organizations' approach to sales and marketing. And then there are the medical transformers, who are focused on more effectively moving drugs from the late stages of clinical development to the patient.On the commercial front, a trend can be seen among the industry's executives on the rise. These individuals acting as agents of change have all been brought in from outside the company with a clear charge to transform the business. In some cases, these companies are clearly looking to organize around key specialty pharma business units. Pharmaceutical executives are well aware that commercial strategies of the last decade are losing effectiveness. At the root of the problem is a profitability- Under the changed scenario,3rd Annual Pharmaceutical draining commercial cost basis, which Leadership Summit 2010 will dwell upon many more issues by results from a sales model that is often industry veterans.....on topics of great importance. I urge you to overly focused on the primary-care attend the high profile event. physician. The short-term solution – Share your thoughts how best I could help you at cutting back on field sales forces – has taken companies about as far as it can. satya.brahma@pharmaleaders.co.in Pharmaceutical companies urgently need Looking forward to see you... a new commercial approach that will either reduce their investment in the Satya Brahma commodity segment or shift it to other Chairman segments that will deliver better returns. Pharmaceutical Leadership Summit 2010 Additionally, to achieve meaningful change, companies will have to rethink not only how they bring their products to market, but also what they bring to the www.pharmaleaders.co.in market.
  • DAY ONE..... World Class Speakers at a glance PROGRAM AGENDA DAY 1 (Friday 25th June 2010) 08:30 – 09:15 AM Registration & Refreshments General Session: Moderator : S. Krishnakumar : Head – Corporate Business Devlopment, Warnbury Ltd 09:15-09:25 AM Opening Address – Satya Brahma, Editor-In-Chief, Pharma Leaders. Release of an exclusive white paper on Booming Pharma Industry – The Road Ahead 2015. 09:25-09:55 AM Welcome Address: Commissioner, FDA, Govt of Maharastra 09:55 – 10.25 AM Keynote Address : Tapan Ray, Director General, OPPI. Obama’s Healthcare policy - An Indian Perspective of its implications. The Patient Protection and Affordable Care Act ,a federal statute that was signed into law in the United States by President Barack Obama on March 23, 2010. Along with the Health Care and Education Reconciliation Act of 2010 (signed into law on March 30, 2010), the Act is a product of the health care reform agenda of the Democratic 111th Congress and the Obama administration.The law includes a large number of health-related provisions to take effect over the next four years, including expanding Medicaid eligibility, subsidizing insurance premiums, providing incentives for businesses to provide health care benefits, prohibiting denial of coverage/claims based on pre-existing conditions, establishing health insurance exchanges, and support for medical research. 10.25 – 10.55 AM Address By Shri Ashok Chavan, Hon’ble Chief Minister, Government of Maharastra. 10.55 – 11.25 AM Address by Shri Srikant Jena, Hon’ble Union Minister of State for Chemicals & Fertilizers, Government of India. 11.25 – 11.55 AM Address by Shri Sanjay Nirupam Hon’ble Member of Parliament, Government of India. 11.55 – 12.25 PM Keynote Address: Dr Surinder Singh,DCGI, Ministry of Health & Family Affairs 11.55 – 12.25 PM Keynote Address: Dr Kamal Sharma, MD, Lupin Ltd. Destination 2010 - Diversification, Expansion & Ambitions 12.25 -12.55 PM Dr Ramakant Panda, Vice-Chairman, Asian Heart Institute. Modern Day Practioners : Aims & Aspirations 12.55-01.25 PM Keynote Address: Leadership in the Face of Change...Mastering Resiliency : The Road Ahead. Kewal Handa : Managing Director – Pfizer Ltd 01.25 -02.25 PM Networking & Luncheon at Majestic Hall
  • 02.25 – 02.55 PM Keynote: Preventive Personalised Healthcare - The way Forward" Dr. Villoo Morawala-Patell, Founder CEO & MD. Avesthagen Limited. Most Indian biotech companies survive by doing reverse engineering or contract work but Morawala-Patell set out to give Avesthagen a strong focus in innovative R&D in diverse areas such as bioAgriculture, bioNutrition, biopharmaceuticals and drug discovery. And now she has split these four strategic business units as four independent profit and loss (P&L) entities, so that it can take care of its own financial requirements. With a fifth of small European biopharmaceutical companies possibly facing bankruptcy by the end of the year, the fear is that many Indian biotech companies could also face the same fate, thanks to the liquidity and credit crisis. The presentation will dwell on about the ripple effect on the Indian biotech 02.55 – 03.25 PM Emergence of Biotech Entrepreneurs : Leadership role in 2010 Dr Krishna Ella, CMD, Bharat Biotech International Ltd. 03:25-03:55 PM Bulk Drug & API’s : Challenges & Opportunities Ahead!!! Dr.B.P. S Reddy, Chairman, Hetro Drugs Ltd The Active Pharmaceutical Ingredient (API) industry in India is gearing up to grab the fast growing global market opportunities through quality manufacturing and R&D activities even as global pharma majors are looking towards low cost quality manufacturing centres in the emerging nations.According to the latest figures from the Bulk Drug Manufacturers Association (BDMA), the size of the API industry is about Rs 32000 crore to Rs 35000 crore ($6.61 billion to $7.23 billion) of the total Rs 78000 crore ($16.12 billion) Indian pharma industry. Out of the total API business, almost Rs 15000 crore to Rs 18000 crore ($3.1 billion to $3.7 billion) comes from exports. 03:55-04.25 PM Medical Representatives :Future Leaders of Robust Indian Pharma Sector. Mr.Deepak Naik, Managing Director, Eisai Pharma Ltd. 04.25-05.00 PM Break – Refreshments 05.00 – 05.30 PM Is the Block-buster Molecule outdated?? Dr R.B.Smarta, Managing Direrctor, Interlink Consultancy Pvt Ltd This panel discussion will bring together leaders in the drug delivery device market with leaders in the drug development market to discuss how alliances can bring sustainable competitive advantage to both groups and the role Leaders has in the selection of a partner. 05:30-06:00 PM The Leadership Journey: Creating and Developing Leadership cramp models in Pharma Industries. Pravin Iyer, CEO, Medreich Ltd When does leadership matter most? How can you use your personal leadership skills to tackle organizational challenges? How can you inspire employees to assume more responsibility for leading themselves? With the simultaneous rise in mergers and acquisitions and the creation of start ups and more autonomous divisions within established companies, the demand for exceptional leadership has never been greater. Cramp Model Analysis.. 06:00-06:30 PM Networking & Refreshments in Exhibition Hall 06:30-07:00 PM Venket Jasti, MD, Suven Life Sciences Ltd. How Pharma Leaders Can Survive and Thrive In Turbulent Times by Embracing Innovation? Turbulent economic times create new opportunities and threats for CI and BI professionals. This presentation will share field research findings regarding traumatic changes under way in the global bio-pharma and medical device sectors – with case examples illuminating how savvy Pharma Leaders and BI pros survive and thrive by aligning organizational intelligence with rapidly changing leadership teams, organizational structures, business units, brands and priorities. . 07.00 –07.30 PM Anand Desai Managing Partner DSK Legal Competitive Intelligence and the Law: Myths and Facts 07:30-08:30 PM Tea & Cofee Break 08.30 –09.15 PM: PANEL DISCUSSION LIVE ON ET NOW : Moderator : Arnab Goswamy : Editor-In-Chief TIMES NOW Kewal Handa :MD, Pfizer Ltd Suresh Kare :CMD, Indoco Remedies Ltd. Pravin Iyer, CEO, Medreich group Dr Kamal Sharma, MD, Lupin Ltd. Sanjay Nirupam, Member of Parliament, Govt of India. Dr Surinder Singh, Drug Controller of India. Dilip Sanghavi, CMD, Sun Pharmaceuticals Ltd. Dr Shailesh Iyenger, MD, Aventis Pharma Ltd. 09.15 – Onwards Cocktails & Dinner
  • DAY TWO..... World Class Speakers at a glance PROGRAM AGENDA DAY 2 (Saturday 26th June 2010) 09:15-10:15 Registration & Networking Breakfast in Exhibition Hall 10:15-11:00 How Pharma Leaders Can Survive and Thrive In Turbulent Times?? Turbulent economic times create new opportunities and threats for CI and BI professionals. This presentation will share field research findings regarding traumatic changes under way in the global bio-pharma and medical device sectors – with case examples illuminating how savvy Pharma Leaders and BI pros survive and thrive by aligning organizational intelligence with rapidly changing leadership teams, organizational structures, business units, brands and priorities. Shailesh Iyenger, MD, Aventis Pharma Ltd. 11:00-12:00 Keynote Address : Is the Indian health care delivery system ready for change? India needs a continuously improving, self-regulating, patient-centred healthcare delivery system. If India is to improve its healthcare delivery mechanism and become a preferred healthcare destination, as pronounced in the National Health Policy, a necessary prerequisite is the setting up of internationally acceptable and highly credible accreditation systems. McKinsey study predicts that in 2012, the healthcare market may well be estimated at US$45bn. Private healthcare is expected to account for 75 percent of this spending. Malvinder Mohan Singh, Group Chairman, Fortis Healthcare & Parkway Holdings 12.00 –12.30 Leadership Lessons from India: The India Way of Leading Business Narayan Gad, CEO - Formulations, Panacea Biotech Ltd. We have come to believe that undergirding the rapid expansion of the Indian economy and the stunning growth of many of its largest companies is an innovative and exportable way of doing business. To understand the Indian way of doing business where the critical decisions of the nation's most important companies are made. 12.30 –01.00 Emergence of Social Devlopment Sector : Corporates need to focus more on CSR? – A Wockhardt Foundation case study: Huzaifa Khorakiwala, CEO, Wockhardt Foundation & Executive Director, Wockhardt Ltd 01.00 – 02.00PM Lunch – Break 2.00 – 2.30 PM Globalisation of alternative therapy market-Challenges and opportunities Mr. Pulin Shroff, MD, Charak Pharma ltd. 02.30 – 03.00 Education through Mid-day meal programs - An overview of The Akshayapatra Foundation Chanchalapati Dasa, Vice Chairman, The Akshayapatra Foundation 03.00 – 03.30 Building Pharma Brands : Challenges & Oppourtunities of Mid-Sized Companies. "Today, the markets have evolved with time. In countries like Russia, consumers are ready to pay a higher cost for quality and there are international competitors who are fighting for a share of these growing markets. The global meltdown could negatively impact Indian pharma exports but "good relationships with the target audience help to sustain longer in the markets.Marketing of pharma products calls for a strong field-force network complimented with a robust supply-chain. A growing product portfolio is the key to beat competition and this will ensure a constant flow of income into the business. J.P.N.Singh, Director, Galpha Labs Ltd 03.30 – 04.15 Destination 2010 Diversification, Expansion & Ambitions Anuj Saxena, Managing Director, Elder Healthcare Ltd. The days when the Indian pharmaceutical industry was synonymous with cheap generic drug production are passing. While generics continue to play a major part in the industry’s success, many companies have started down the long road of drug discovery and branded product development.
  • 04:15-04:45 100 Prescriptions for 1 Lac : Is the era of ethical marketing over? Ruth D’ souza, Executive Director, Interlink Marketing Consultancy Pvt Ltd. In what seems to be a case of giving the fox the job of guarding the henhouse, the government has decided to curb the practice of bribing doctors for promoting drugs by allowing pharmaceutical companies to self-regulate rather than have a legislation to tackle the menace. This is despite the fact that more than a quarter of the members of the Organisation of Pharmaceutical Producers of India (OPPI) an association mainly of multinationals which is estimated to account for 70% of the drug market in India are subsidiaries of companies that have been penalised in the US for illegally promoting various drugs through inducements for doctors. Of the 53 pharma members of the OPPI, over 25% have figured in such cases in the US. This is despite the fact that Pharmaceutical Research and Manufacturers of America (PhRMA), which includes many of these penalised companies, already has a voluntary Code on Interactions with Health Professionals which explicitly prohibits members from giving illegal inducements to doctors to get them to prescribe their products. 04.45 – 05.15 Can we face the Heat of Globalization ? Ram Prasad Reddy, Chairman, Aurobindo Pharma Ltd 05.15 – 05.45 Mr Ramesh Adige, Global Director – Communications , Ranbaxy Ltd. Is India marching ahead towards social enterprenuership 05.45 – 06.15 Networking & Refreshments in Exhibition Hall 06.15 – 06.45 Retail Pharmacy Market in India : Suneeta Reddy, Group CFO, Appolo Group. The number of present pharmacies in the country, estimated over 5 lacks, has to be looked from a practical positive angle. They too have a role to play - to make the medicines available to the common man at affordable cost.They have survived amidst odds and unhealthy competition due to irrational grant of too many sales licences, unmindful of the need. The industry is growing at 41% per annum and expected to reach INR 432 bn by 2011. Growth in this sector is being propelled by increase in healthcare spending, growth in pharma sector & organized pharma retail, changing disease profile of India, consumer attitudes, attractive margins and growth in OTC segment. 6.45 - 7-15 The Essence of living- perspectives from dietry guidelines and nutritional suppliments Dr Anjali Mukharjee, noted Nutritionist 07.15 – 07.45 Authorised Generics-Threats or opportunities Keynote Address : Satish Reddy, CEO & MD, Dr Reddy’s Labs Ltd. With low-cost manufacturing, high-quality research and manufacturing facilities and educated personnel, the Indian pharmaceutical industry presents both a competitive threat and partner opportunities. India is the world’s fourth largest producer of pharmaceuticals by volume, accounting for around 8% of global production. In value terms, production accounts for around 1.5% of the world total. The Indian pharmaceutical industry directly employs around 500,000 people and is highly fragmented. While there are around 270 large R&D based pharmaceutical companies in India, including multinationals, government-owned and private companies, there are also around 5,600 smaller licensed generics manufacturers, although in reality only around 3,000 companies are involved in pharmaceutical production. Most small firms do not have their own production facilities, but operate using the spare capacity of other drug manufacturers. 07:45-08:45.: Vote of Thanks : Satya Brahma, Editor-In-Chief, Pharma Leaders, followed by Pharmaceutical Leadership Awards 8.45 onwards Cocktail & Dinner with a grand Gala evening Surprise THE DOYENS OF THESE SPEAKERS WILL BRAINSTORM AT PHARMACEUTICAL LEADERSHIP SUMMIT 2010 A power packed audience watching the proceedings in full flow
  • Don’t miss a single presentation! Reserve your place today at pharmaleaders@pharmaleaders.co.in Reasons to attend Cutting edge Pipeline Strategy workshop 350 Senior executives 60 Thought-leading speakers Summit White Paper 5 EASY STEPS 18 Hours networking Exclusive Speakers presentation material TO REGISTER Meet 350 senior level marketing executives CALL +91 22 2666656 Breakdown of last year’ FAX +91 22 2666463 Head of Marketing / Marketing Director EMAIL pharmaleaders CEO / Managing Director / General Manager @pharmaleaders.co.in Brand Manager / Product Manager CELL +91 9920246286 Commercial & Marketing Manager +91 8147710295 Consultants / Solution Providers ONLINE www.pharmaleaders.co.in Press MEDIA PARTNERS BIOTECH MAGAZINE PARTNER KNOWLEDGE PARTNER CREATIVE DESIGN PARTNER PRINTING & PACKAGING PARTNER HEALTHCARE MEDIA PARTNER GIFT PARTNER RADIO PARTNER ONLINE PARTNER PHARMA HR PARTNER IN ASSOCIATION WITH BROUGHT TO PHARMA CSR MIDDAY MEAL YOU BY PARTNER PARTNER www.indioppi.com www.idma.org www.ipa.org www.pharmexcil.com www.bdma.com www.integrralmedia.com www.wockhardtfoundtion.org www.akshayapatra.org
  • Plan now to participate industry’s much awaited leadership awards THE MAGAZINE FOR THE PHARMA LEADERS presents PHARMACEUTICAL Saturday,26th June,2010, LEADERSHIP AWARDS 2010 Majestic Hall, Hotel Intercontinental, Mumbai ,India. Honouring Excellence in Healthcare & Pharmaceuticals “LIMITLESS LEADERSHIP” BRINGING TODAY,TOMORROW & BEYOND
  • VOTE ONLINE YOUR FAVOURITE LEADERS @ www.pharmaleaders.co.in The pharma industry is facing some tough times—and the old way of doing things just won't work. So just who are the new leaders steering the industry though its most difficult challenges? Which executives are revamping the industry—through pure innovation—to Award Categories – 2010. remake it for the 21st century? 1. Brand of The Year. 2. Pharma Professional of the Year. An independent 3. Businessman of the year panel of prominent society and industry 4. Company of the year leaders will judge the 5. Best Company in R&D Excellence. awards. Winners will be selected prior to 6. Dynamic Entrepreneur of The Year. the WIL India Awards 7. Emerging Company of The Year. ceremony. Judging will be based on 8. India's Most Admired Pharma Company. information provided 9. Research Scientist of The Year. by the nominees. Finalists will be 10. Excellence in Bulk Drugs & Exports notified in advance - 11. Hottest Exports Company of the Year. in writing. The final winners will be 12. Company of the year ( SME) announced at the 13. India's Most Watched Company of the year. awards evening, on Saturday, 26th June, 14. Excellence in Nutrition & Nutraceuticals 15. Best Product Launch of the year. 16. Excellence in Pharmacy & Community Healthcare profession. 17. India's Most Advanced Manufacturing Company. 18. OTC Company of the year. 19. Businesswoman of the year. 20. Lifetime Achievement Award 2010. Flashback memorable moments of Pharmaceutical Leadership Awards
  • Pharmaceutical Leadership Summit & Awards redefined PHARMACEUTICAL LEADERSHIP 2010 AWARDS 2010 “LIMITLESS LEADERSHIP” BRINGING TODAY, Honouring Excellence in Healthcare & Pharmaceuticals TOMORROW & BEYOND SUMMIT PARTNERS HOSPITALITY PARTNER LEADERSHIP PARTNER KNOWLEDGE PARTNER PRINTING & PACKAGING PARTNER MEDIA PARTNERS BIOTECH MAGAZINE PARTNER KNOWLEDGE PARTNER CREATIVE DESIGN PARTNER PRINTING & PACKAGING PARTNER HEALTHCARE MEDIA PARTNER PHARMA HR PARTNER GIFT PARTNER RADIO PARTNER ONLINE PARTNER SUMMIT AWARD PARTNER IN ASSOCIATION WITH BROUGHT TO PHARMA CSR MIDDAY MEAL YOU BY PARTNER PARTNER www.indioppi.com www.idma.org www.ipa.org www.pharmexcil.com www.bdma.com www.integrralmedia.com www.wockhardtfoundtion.org www.akshayapatra.org Summit Secretariat: CALL +91 22 2666656 Speak to our friendly event specialists for your tailor made requirements : Integral Media Pvt Ltd. 3A, Central Plaza, 166 C.S.T. FAX +91 22 2666463 Debashish Chakrabartty +91 8147710295 +91 9590355290 Road,Kalina, Santacruz (E),Mumbai, EMAIL pharmaleaders@pharmaleaders.co.in Maharastra,Pin : 400 098, India. Panduranga Rao Patil ONLINE www.pharmaleaders.co.in +91 9920246286, +91 7738741178 Fax: 91-22-2666 6463